Newman Dignan & Sheerar, Inc. Solid Biosciences Inc. Transaction History

Newman Dignan & Sheerar, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$0.51 - $7.56 $7,661 - $113,573	15,023 New	15,023 $7,000
Q1 2022 Apr 14, 2022	SELL	$0.74 - $1.79 $8,897 - $21,521	-12,023 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$1.69 - $2.46 $3,380 - $4,920	2,000 Added 19.95%	12,023 $21,000
Q3 2021 Oct 07, 2021	BUY	$2.38 - $3.77 $23,854 - $37,786	10,023 New	10,023 $24,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.